Humacyte (HUMA) Other Working Capital Changes (2021 - 2025)

Humacyte (HUMA) has reported Other Working Capital Changes for 5 consecutive years, with -$15000.0 the latest figure, recorded in Q3 2025.

• On a quarterly basis, Other Working Capital Changes fell 15.38% year-over-year to -$15000.0 in Q3 2025; TTM through Jun 2026 was -$15000.0, a 73.21% increase from a year earlier, with the FY2025 full-year figure at -$44000.0, up 16.98% from the prior year.
• Other Working Capital Changes was -$15000.0 for Q3 2025 at Humacyte, roughly flat from -$15000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at -$10000.0 in Q2 2021 and troughed at -$15000.0 in Q2 2025.
• A 5-year average of -$12315.8 and a median of -$12000.0 in 2022 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes changed 0.0% in 2022 and dropped 18.18% in 2023, its largest moves.
• Over 5 years, Other Working Capital Changes stood at -$10000.0 in 2021, then slipped by 10.0% to -$11000.0 in 2022, then decreased by 18.18% to -$13000.0 in 2023, then retreated by 7.69% to -$14000.0 in 2024, then declined by 7.14% to -$15000.0 in 2025.
• The last three Other Working Capital Changes figures came in at -$15000.0 (Q3 2025), -$15000.0 (Q2 2025), and -$14000.0 (Q1 2025), per Business Quant data.